Anzeige
LABVOLUTION 2019, 21.-23. Mai
Startseite>Sprecherübersicht >Dr. Klaus-Michael Weltring

Dr. Klaus-Michael Weltring

Gesellschaft für Bioanalytik, Dr. Klaus-Michael Weltring

Firma

Gesellschaft für Bioanalytik


Deutschland

Dr. Klaus-Michael Weltring is a molecular biologist by training with a PhD and a Habilitation degree from the University of Münster. Since 2001 he is the managing director of bioanalytik-muenster responsible for the development of the Münster region into a leading nanobioanalytic location at the European level. Between 2003 and 2008 he was the deputy-coordinator of the Nano2Life Network of Excellence and leader of the "ELSA" Board in this network. He co-managed the Nanomedicine Round Table and the EuroNanoBio projects and participated in the NANOMED2020 project (FP7 CSA projects). Since 2009 he is a member of the Executive Board of the ETP Nanomedicine leading the ELSA Advisory Group of this platform. Since March 2015 he is the chair of the German platform NanoBioMedicine. At the local level he is the Chief Scientific Officer of the Nano-Bioanalytik-Zentrum Münster (NBZ) and manages the Nano-Characterization-Lab Muenster (http://www.NCL-Muenster.de) interfacing 11 local companies which develop new and certified methods for characterization of Nanomaterials in consumer products and biological systems. Currently he is partner in the EU-projects ENATRANS and EU-NCL

Auf der Merkliste

0

Das Merken ist fehlgeschlagen, da ein Problem mit der Verbindung zum Server aufgetreten ist.